Literature DB >> 9846563

From genomics to vaccines: malaria as a model system.

S L Hoffman1, W O Rogers, D J Carucci, J C Venter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9846563     DOI： 10.1038/3934

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  18 in total

1.  HLA-A*01-restricted cytotoxic T-lymphocyte epitope from the Plasmodium falciparum circumsporozoite protein.

Authors:  A Kumar; S Kumar; T P Le; S Southwood; J Sidney; J Cohen; A Sette; S L Hoffman
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Role of HtrA in the virulence and competence of Streptococcus pneumoniae.

Authors:  Yasser Musa Ibrahim; Alison R Kerr; Jackie McCluskey; Tim J Mitchell
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

3.  CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.

Authors:  Y Charoenvit; V F Majam; G Corradin; J B Sacci; R Wang; D L Doolan; T R Jones; E Abot; M E Patarroyo; F Guzman; S L Hoffman
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 4.  Current status of malaria and potential for control.

Authors:  R S Phillips
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

5.  Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes.

Authors:  H Hisaeda; A W Stowers; T Tsuboi; W E Collins; J S Sattabongkot; N Suwanabun; M Torii; D C Kaslow
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.

Authors:  D L Narum; S Kumar; W O Rogers; S R Fuhrmann; H Liang; M Oakley; A Taye; B K Sim; S L Hoffman
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  High-throughput generation of P. falciparum functional molecules by recombinational cloning.

Authors:  João Carlos Aguiar; Joshua LaBaer; Peter L Blair; Victoria Y Shamailova; Malvika Koundinya; Joshua A Russell; Fengying Huang; Wenhong Mar; Robert M Anthony; Adam Witney; Sonia R Caruana; Leonardo Brizuela; John B Sacci; Stephen L Hoffman; Daniel J Carucci
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

8.  Microbial genomics: from sequence to function.

Authors:  I Schwartz
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

9.  Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.

Authors:  Said A Jongo; L W Preston Church; Ali T Mtoro; Tobias Schindler; Sumana Chakravarty; Adam J Ruben; Phillip A Swanson; Kamaka R Kassim; Maximillian Mpina; Anneth-Mwasi Tumbo; Florence A Milando; Munira Qassim; Omar A Juma; Bakari M Bakari; Beatus Simon; Eric R James; Yonas Abebe; Natasha Kc; Elizabeth Saverino; Martina Fink; Glenda Cosi; Linda Gondwe; Fabian Studer; David Styers; Robert A Seder; Tobias Schindler; Peter F Billingsley; Claudia Daubenberger; B Kim Lee Sim; Marcel Tanner; Thomas L Richie; Salim Abdulla; Stephen L Hoffman
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079

10.  A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.

Authors:  Eric Prieur; Sarah C Gilbert; Joerg Schneider; Anne C Moore; Eric G Sheu; Nilu Goonetilleke; Kathryn J H Robson; Adrian V S Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.